Modifications of leucocyte function in visceral leishmaniasis.
D000328:Adult; D000965:Antimony / Q000627:therapeutic use; D000981:Antiprotozoal Agents / Q000627:therapeutic use; D001770:Blood Bactericidal Activity; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000097:blood* / Q000188:drug therapy; D007958:Leukocyte Count; D008297:Male; D008536:Meglumine / Q000031:analogs & derivatives / Q000627:therapeutic use; D008875:Middle Aged; D009504:Neutrophils / Q000502:physiology*; D010587:Phagocytosis
D000981:Antiprotozoal Agents; C006601:antimony-N-methylglucamine; D008536:Meglumine; D000965:Antimony